| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |